Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Befano

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of the National Cancer Institute|April 11, 2023
Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine TrialBrian Befano, Nicole G Campos, Didem Egemen, et al.
Gynecologic Oncology|May 27, 2023
The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinomaMark Schiffman, Lisa Mirabello, Didem Egemen, et al.
American Journal of Obstetrics and Gynecology|December 8, 2024
Associations of obesity with post-treatment risks of cervical precancer and cancerMegan A Clarke, Brian Befano, Nicolas Wentzensen, et al.
Journal of the National Cancer Institute|February 17, 2022
Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and ManagementJacqueline Mix, Mona Saraiya, Benjamin D Hallowell, et al.
International Journal of Cancer|September 29, 2023
A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional studyFederica Inturrisi, Silvia de Sanjosé, Kanan T Desai, et al.
Cancer Research|April 1, 2010
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasiaMark Schiffman, Ana Cecilia Rodriguez, Zigui Chen, et al.
Medical Image Learning with Limited and Noisy Data : First International Workshop, Milland 2022, Held in Conjunction with MICCAI 2022, Singapore, September 22, 2022, Proceedings. Milland (Workshop) (1St : 2022 : Singapore)|October 31, 2022
Image Quality Classification for Automated Visual Evaluation of Cervical PrecancerZhiyun Xue, Sandeep Angara, Peng Guo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2018
Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of PrecancerMegan A Clarke, Barbara Fetterman, Li C Cheung, et al.
Journal of Lower Genital Tract Disease|April 4, 2020
Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus GuidelinesDidem Egemen, Li C Cheung, Xiaojian Chen, et al.
Elife|January 15, 2024
Design of the HPV-automated visual evaluation (PAVE) study: Validating a novel cervical screening strategySilvia de Sanjosé, Rebecca B Perkins, Nicole Campos, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of the National Cancer Institute|April 11, 2023
Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine TrialBrian Befano, Nicole G Campos, Didem Egemen, et al.
Gynecologic Oncology|May 27, 2023
The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinomaMark Schiffman, Lisa Mirabello, Didem Egemen, et al.
American Journal of Obstetrics and Gynecology|December 8, 2024
Associations of obesity with post-treatment risks of cervical precancer and cancerMegan A Clarke, Brian Befano, Nicolas Wentzensen, et al.
Journal of the National Cancer Institute|February 17, 2022
Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and ManagementJacqueline Mix, Mona Saraiya, Benjamin D Hallowell, et al.
International Journal of Cancer|September 29, 2023
A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional studyFederica Inturrisi, Silvia de Sanjosé, Kanan T Desai, et al.
Cancer Research|April 1, 2010
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasiaMark Schiffman, Ana Cecilia Rodriguez, Zigui Chen, et al.
Medical Image Learning with Limited and Noisy Data : First International Workshop, Milland 2022, Held in Conjunction with MICCAI 2022, Singapore, September 22, 2022, Proceedings. Milland (Workshop) (1St : 2022 : Singapore)|October 31, 2022
Image Quality Classification for Automated Visual Evaluation of Cervical PrecancerZhiyun Xue, Sandeep Angara, Peng Guo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2018
Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of PrecancerMegan A Clarke, Barbara Fetterman, Li C Cheung, et al.
Journal of Lower Genital Tract Disease|April 4, 2020
Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus GuidelinesDidem Egemen, Li C Cheung, Xiaojian Chen, et al.
Elife|January 15, 2024
Design of the HPV-automated visual evaluation (PAVE) study: Validating a novel cervical screening strategySilvia de Sanjosé, Rebecca B Perkins, Nicole Campos, et al.
Pageof 6